Apellis Pharmaceuticals

Apellis Pharmaceuticals' Medicines

Apellis Pharmaceuticals is dedicated to developing life-changing medicines, primarily targeting the central protein in the complement cascade, C3. This innovative approach allows the company to provide comprehensive control over a variety of debilitating diseases. Apellis has successfully brought two C3-targeting medicines to market, addressing significant unmet medical needs. These medicines represent a breakthrough in treatment options for patients suffering from rare, retinal, and neurological diseases, underscoring Apellis' commitment to pioneering therapies that enhance patient outcomes.

Apellis Pharmaceuticals' Clinical Programs

Apellis Pharmaceuticals is at the forefront of medical innovation with nearly a dozen clinical and pre-clinical programs actively underway. These programs span a diverse range of therapeutic areas, including rare diseases, retinal disorders, and neurological conditions. By focusing on these specific areas, Apellis aims to address high unmet medical needs and improve the quality of life for patients worldwide. The company’s robust pipeline reflects its strategic commitment to harnessing the potential of complement inhibition as a therapeutic strategy.

Apellis Pharmaceuticals' Global Presence

Apellis Pharmaceuticals maintains a strong global presence with offices strategically located in the United States, Switzerland, Germany, and Australia. This international footprint enables the company to effectively collaborate with global partners, access diverse markets, and bring its innovative therapies to patients around the world. The presence in multiple regions also facilitates the company's ability to conduct extensive clinical trials and regulatory activities across different jurisdictions, thereby accelerating the development and availability of its treatments.

Apellis Pharmaceuticals' Employee Benefits

Apellis Pharmaceuticals is committed to supporting its employees through a flexible and remote working model that caters to individual needs. The company offers a comprehensive total rewards program designed to support the health, well-being, and future success of its employees and their families. This program includes competitive compensation, health benefits, and opportunities for professional development. By fostering a supportive and inclusive work environment, Apellis ensures that its workforce is motivated and equipped to drive the company’s mission forward.

Apellis Pharmaceuticals' Ethical Standards

Apellis Pharmaceuticals upholds high ethical standards through its Supplier Code of Conduct, which ensures responsible sourcing and ethical business practices. This code mandates that all suppliers adhere to stringent guidelines related to labor practices, environmental sustainability, and corporate governance. By enforcing these standards, Apellis reinforces its commitment to ethical business operations and corporate responsibility. The Supplier Code of Conduct not only aligns with the company's values but also promotes a culture of integrity and accountability throughout its supply chain.